SVA Sinovac Biotech, Ltd.

Sinovac Biotech Ltd is a biopharmaceutical company engaged in research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases.

As of 01/05/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  China
Country of incorporation:  
IPO date:  12/31/1969
Outstanding shares:  99,502,243
Average volume:  0
Market cap:   $643,779,512
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      2384520
Valuation   (See tab for details)
PE ratio:   6.17
PB ratio:   0.11
PS ratio:   1.26
Return on equity:   1.88%
Net income %:   21.61%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy